Alkermes Plc (ALKS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | ALKS | AMGN | GILD | BIIB | CELG |
| Company | Alkermes Plc | Amgen Inc | Gilead Sciences Inc | Biogen Inc | Celgene Corp |
| Price Information | |||||
| Exchange | NASDAQ | NASDAQ | NASDAQ | NASDAQ | NASDAQ |
| Open | 28.26 | 337.03 | 84.39 | 200.57 | 108.01 |
| High | 28.44 | 338.70 | 84.65 | 204.18 | 108.59 |
| Low | 27.99 | 334.61 | 83.57 | 200.11 | 107.27 |
| Last | 28.28 | 336.16 | 84.40 | 202.31 | 108.24 |
| Change | +0.45 | +3.24 | +0.51 | +4.72 | +0.11 |
| % Change | +1.62% | +0.97% | +0.61% | +2.39% | +0.10% |
| Volume | 445,777 | 676,482 | 3,832,582 | 539,914 | 191,230,496 |
| 20-Day Average Volume | 1,305,861 | 1,710,155 | 6,431,765 | 797,132 | 16,188,930 |
| Previous Close | 27.83 | 332.92 | 83.89 | 197.59 | 108.13 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | Yes | Yes | Yes | Yes | No |
| Technicals | |||||
| 20-Day Moving Average | 27.70 | 329.64 | 80.11 | 201.73 | 108.17 |
| 20-Day Raw Stochastic | 89.98% | 90.60% | 97.17% | 80.67% | 63.25% |
| 20-Day Relative Strength | 59.33% | 58.53% | 73.21% | 48.40% | 64.69% |
| Weighted Alpha | +3.89 | +27.70 | +19.64 | -20.28 | +46.30 |
| Today's Opinion | 80% Buy | 96% Buy | 88% Buy | 88% Sell | 100% Buy |
| Previous Opinion | 72% Buy | 88% Buy | 88% Buy | 100% Sell | 100% Buy |
| Last Month's Opinion | 56% Buy | 88% Buy | 56% Buy | 88% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +6.87% since 09/12/24 | +2.14% since 09/12/24 | +1.76% since 09/12/24 | +3.06% since 09/12/24 | -1.97% since 11/13/19 |
| Low | 26.75 on 09/13/24 | 327.15 on 09/13/24 | 81.57 on 09/13/24 | 192.25 on 09/13/24 | 107.27 on 11/20/19 |
| High | 28.47 on 09/17/24 | 339.00 on 09/18/24 | 84.65 on 09/19/24 | 204.18 on 09/19/24 | 110.53 on 11/14/19 |
| 1-Month | |||||
| %Chg | +0.55% since 08/19/24 | +2.79% since 08/19/24 | +13.66% since 08/19/24 | -1.02% since 08/19/24 | +5.14% since 10/18/19 |
| Low | 25.65 on 09/10/24 | 319.00 on 09/06/24 | 74.34 on 08/20/24 | 192.25 on 09/13/24 | 102.40 on 10/21/19 |
| High | 28.69 on 08/27/24 | 339.00 on 09/18/24 | 84.89 on 09/12/24 | 207.59 on 08/21/24 | 110.70 on 11/13/19 |
| 3-Month | |||||
| %Chg | +16.24% since 06/18/24 | +10.17% since 06/18/24 | +34.00% since 06/18/24 | -8.81% since 06/18/24 | +13.63% since 08/20/19 |
| Low | 22.90 on 07/10/24 | 303.55 on 06/20/24 | 64.86 on 06/20/24 | 192.25 on 09/13/24 | 93.41 on 08/23/19 |
| High | 28.95 on 07/26/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| 6-Month | |||||
| %Chg | +2.47% since 03/19/24 | +24.06% since 03/19/24 | +15.27% since 03/19/24 | -6.71% since 03/19/24 | +14.14% since 05/20/19 |
| Low | 22.90 on 07/10/24 | 260.68 on 04/19/24 | 62.07 on 05/31/24 | 189.44 on 04/19/24 | 89.08 on 07/23/19 |
| High | 28.95 on 07/26/24 | 346.85 on 07/25/24 | 84.89 on 09/12/24 | 238.00 on 07/12/24 | 110.70 on 11/13/19 |
| Key Statistics | |||||
| Market Capitalization, $K | 4,709,421 | 178,589,936 | 104,514,608 | 28,768,510 | 77,035,920 |
| Shares Outstanding, K | 169,221 | 536,435 | 1,245,853 | 145,597 | 711,714 |
| Annual Sales | 1,663,410,000 | 28,190,000,000 | 27,116,000,000 | 9,835,600,000 | 15,281,000,000 |
| Annual Net Income | 355,760,000 | 6,717,000,000 | 5,665,000,000 | 1,161,100,000 | 4,046,000,000 |
| Last Quarter Sales | 399,130,000 | 8,388,000,000 | 6,954,000,000 | 2,464,900,000 | 4,520,000,000 |
| Last Quarter Net Income | 91,360,000 | 746,000,000 | 1,614,000,000 | 583,600,000 | 1,691,000,000 |
| 60-Month Beta | 0.46 | 0.61 | 0.18 | -0.06 | 1.41 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.72 on 07/24/24 | 4.97 on 08/06/24 | 2.01 on 08/08/24 | 5.28 on 08/01/24 | 2.99 on 10/31/19 |
| Latest Earnings Date | 10/23/24 | 10/29/24 | 11/05/24 | 08/01/24 | 10/31/19 |
| Most Recent Dividend | N/A | 2.250 on 08/16/24 | 0.770 on 09/13/24 | N/A | N/A |
| Next Ex-Dividends Date | N/A | 08/16/24 | 09/13/24 | N/A | N/A |
| Ratios | |||||
| Price/Earnings ttm | 16.03 | 17.89 | 17.67 | 12.19 | 10.99 |